The Next Generation of JAK Inhibitors: an Update on Fedratinib, Momelotonib, and Pacritinib
Anand Patel, Olatoyosi Odenike
Topics & Concepts
RuxolitinibMyelofibrosisMedicineInternal medicineMyeloproliferative neoplasmExtramedullary hematopoiesisAnemiaClinical trialOncologyBone marrowHaematopoiesisStem cellGeneticsBiologyMyeloproliferative Neoplasms: Diagnosis and TreatmentMultiple Myeloma Research and TreatmentsChronic Myeloid Leukemia Treatments